<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Diagnostic Efficacy and Safety of Computed Tomography-Guided Transthoracic Needle Biopsy in Patients with Hematologic Malignancies" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/diagnostic-efficacy-and-safety-of-computed-tomography-guided-transthoracic-needle-biopsy-in-patients/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/diagnostic-efficacy-and-safety-of-computed-tomography-guided-transthoracic-needle-biopsy-in-patients/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2009-10-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Diagnostic Efficacy and Safety of Computed Tomography-Guided Transthoracic Needle Biopsy in Patients with Hematologic Malignancies" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-07T07:15:32+00:00","datePublished":"2009-10-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Diagnostic Efficacy and Safety of Computed Tomography-Guided Transthoracic Needle Biopsy in Patients with Hematologic Malignancies","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/diagnostic-efficacy-and-safety-of-computed-tomography-guided-transthoracic-needle-biopsy-in-patients/"},"url":"https://clinicaltree.github.io/posts/diagnostic-efficacy-and-safety-of-computed-tomography-guided-transthoracic-needle-biopsy-in-patients/"}</script><title>Diagnostic Efficacy and Safety of Computed Tomography-Guided Transthoracic Needle Biopsy in Patients with Hematologic Malignancies | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Diagnostic Efficacy and Safety of Computed Tomography-Guided Transthoracic Needle Biopsy in Patients with Hematologic Malignancies</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Diagnostic Efficacy and Safety of Computed Tomography-Guided Transthoracic Needle Biopsy in Patients with Hematologic Malignancies</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1257008400" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Oct 31, 2009 </em> </span> <span> Updated <em class="" data-ts="1680851732" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 7, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Marije H. Kallenberg</a> </em>, <em> <a href="">Ritu R. Gill MD</a> </em>, <em> <a href="">Rachel E. Factor MD</a> </em>, <em> <a href="">Julie M. Bryar BA</a> </em>, <em> <a href="">Robert H. Rubin MD</a> </em>, <em> <a href="">Francine L. Jacobson MD MPH</a> </em>, <em> <a href="">Francisco M. Marty MD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="2046 words"> <em>11 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The role of transthoracic needle biopsy (TTNB) in patients with hematologic malignancies, particularly in discriminating between malignant and benign etiologies, has not been well studied. Hence, the diagnostic efficacy and safety of computed tomography–guided TTNB were retrospectively evaluated in this population.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The records of 53 patients with hematologic malignancies who underwent TTNB from August 1, 1999, to July 31, 2007, were reviewed. Potential factors for increased diagnostic yield and risk for complications were collected and analyzed, including the status of neutropenia, thrombocytopenia, chemotherapy, and transplant as well as lesion size and location. Both cytopathologic and microbiologic results were assessed.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The most common underlying hematologic malignancy was non-Hodgkin lymphoma, in 20 patients (37.7%). Lesions were most frequently located in the left upper lobe (16 [30.2%]); 33 lesions were pleural based (63.5%), and nine had cavitation (17.0%). TTNB established specific diagnoses in 22 patients (41.5%): malignancies was found in 12 (22.6%) and infections in 10 (18.9%). Sensitivity for detecting malignancy was 50.0%, and sensitivity for the detection of a specific infection was 40.0%. There were no false-positive results. Complications occurred in nine patients (17.0%): self-limited small-volume hemoptysis in one patient (1.9%) and pneumothorax in eight patients (15.1%), one requiring chest tube placement. The results of TTNB led to changes in antimicrobial therapy for eight of the 22 patients with specific diagnoses (36.4%).</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>TTNB is a safe diagnostic procedure in patients with hematologic malignancies and has the potential of making specific diagnoses with minimal morbidity.</p><p>Pulmonary syndromes are relatively common in patients with hematologic malignancies . Although infections are a major concern, the differential diagnosis includes infectious (viral, bacterial, fungal, parasitic) and noninfectious (malignancy, drug toxicity, inflammatory disorders) etiologies . Concurrent pulmonary pathologic processes are common . Routine chest radiography and sputum samples usually fail to diagnose concomitant pathologies , especially in patients with chemotherapy-induced neutropenia and empirical therapy .</p><p>Establishing a diagnosis is difficult in this population; early diagnosis and prompt initiation of effective therapy are crucial for successful clinical outcomes and subsequent management . Additionally, an aggressive approach to diagnosis limits unnecessary drug toxicity and exposure to potentially inadequate therapy .</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="patient-cohort"><span class="mr-2">Patient Cohort</span><a href="#patient-cohort" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="data"><span class="mr-2">Data</span><a href="#data" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="ttnb-procedure"><span class="mr-2">TTNB Procedure</span><a href="#ttnb-procedure" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="cytopathologic-review"><span class="mr-2">Cytopathologic Review</span><a href="#cytopathologic-review" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="definitions"><span class="mr-2">Definitions</span><a href="#definitions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Patient Characteristics</p><p>Characteristic Value Patients 53 Sex Female 24 (45.3%) Male 29 (54.7%) Age at time of TTNB (y) 57 (43 to 68, 20 to 83) Underlying hematologic disease NHL 20 (37.7%) AML 10 (18.9%) MDS 5 (9.4%) HD 5 (9.4%) CLL 5 (9.4%) CML 3 (5.7%) Other ∗ 5 (9.4%) HSCT None 40 (75.5%) Allogeneic 8 (15.1%) Autologous 5 (9.4%) Time between HSCT and TTNB (mo) ( <em>n</em> = 13) 4.9 (3.4 to 22.7, 0.9 to 42.5) Time between last cycle of chemotherapy and TTNB (mo) ( <em>n</em> = 47) 1.9 (0.63 to 5.9, 0 to 125.5) Patients with neutropenia Not within 1 month before TTNB nor at TTNB 25 (47.2%) Within 1 month before TTNB, not at TTNB 15 (28.3%) At TTNB ( <em>n</em> = 43) † 13 (24.5%) Platelet count at TTNB (×10 3 /μL) ( <em>n</em> = 43) † 95 (67 to 194, 9 to 461) Patients with thrombocytopenia at TTNB (%) 23 (44.2%) Patients who received platelets before TTNB 22 (41.5%) Platelet count at TTNB (×10 3 /μL) 67 (56 to 77, 9 to 101) Platelet increase after transfusion (×10 3 /μL) 24 (9 to 38, −14 to 77)</p><p>AML, acute myelogenous leukemia; CLL, chronic lymphocytic leukemia; CML, chronic myelogenous leukemia; HD, Hodgkin’s disease; HSCT, hematopoietic stem cell transplantation; MDS, myelodysplastic syndrome; NHL, non-Hodgkin lymphoma; TTNB, transthoracic needle biopsy.</p><p>Data are expressed as number (percentage) or as median (interquartile range, range).</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="imaging-characteristics"><span class="mr-2">Imaging Characteristics</span><a href="#imaging-characteristics" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 2</p><p>Imaging Characteristics of Lesions That Underwent TTNB and Relationship to Specific Diagnoses</p><p>Characteristic Number of Cases (% of Total) Cases Providing Specific Diagnoses ( <em>n</em> = 22) Cases Providing No Specific Diagnosis ( <em>n</em> = 31)<em>P</em> Cavitation 9 (17.0%) 5 (22.7%) 4 (12.9%) .46 Pleural based ∗ 33 (62.3%) 11 (50.0%) 22 (71.0%) .16 Lesion size (cm 2 ) 8.9 (1.7–57.0) 7.8 (2.3–41.8) 10.5 (1.7–57.0) .88 Lesion location .73 LUL 16 (30.2%) 9 (31.8%) 7 (22.6%) LLL 10 (18.9%) 3 (13.6%) 7 (22.6%) RUL 9 (17.0%) 5 (22.7%) 4 (12.9%) RLL 8 (15.1%) 3 (13.6%) 5 (16.1%) RML 5 (9.4%) 1 (4.6%) 4 (12.9%) Other thoracic locations † 5 (9.4%) 3 (13.6%) 2 (6.5%)</p><p>LLL, left lower lobe; LUL, left upper lobe; RLL, right lower lobe; RML, right middle lobe; RUL, right upper lobe; TTNB, transthoracic needle biopsy.</p><p>Data are expressed as number (percentage) or as median (interquartile range).</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="procedure"><span class="mr-2">Procedure</span><a href="#procedure" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 3</p><p>Complications of TTNB and Relationships to Thrombocytopenia, Lesion Location, and Number of Needle Passes</p><p>Risk Factor Total Number TTNB with Complication ( <em>n</em> = 9) TTNB without Complication ( <em>n</em> = 44)<em>P</em> Thrombocytopenia (%) 23 (44.2%) 3 (13%) 20 (87%) .69 Location of lesion .07 Pleural 33 (62.3%) 3 (9.1%) 30 (90.9%) Nonpleural 20 (37.7%) 6 (30%) 14 (70%) Number of passes 2 (1–5) 1 (1–3) 2 (1–5) .07</p><p>TTNB, transthoracic needle biopsy.</p><p>Data are expressed as number (percentage) or as median (range).</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="diagnostic-efficacy"><span class="mr-2">Diagnostic Efficacy</span><a href="#diagnostic-efficacy" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 4</p><p>Specific Diagnoses Provided by TTNB (Diagnostic Efficacy) and Final Specific Diagnoses Established After TTNB</p><p>Diagnosis Diagnosis Provided by TTNB Final Diagnosis Established Malignancy 12 24 Lung cancer 5 ∗ 7 Recurrent lymphoma 7 16 Presumed lymphoma 0 1 † Infection 10 25<em>Aspergillus</em> 4 6<em>Nocardia</em> 2 2<em>Candida</em> 1 1 Zygomycetes 1 1 Bacterial infection 1 1<em>Actinomyces odontolyticus</em> 1 2<em>Alternaria</em> , disseminated 0 1 Presumed 0 11 ‡ No diagnosis § 31 — ‖</p><p>TTNB, transthoracic needle biopsy.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DiagnosticEfficacyandSafetyofComputedTomographyGuidedTransthoracicNeedleBiopsyinPatientswithHematologicMalignancies/0_1s20S1076633209003614.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DiagnosticEfficacyandSafetyofComputedTomographyGuidedTransthoracicNeedleBiopsyinPatientswithHematologicMalignancies/0_1s20S1076633209003614.jpg" alt="Figure 1, TTNB sample allocation and results." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 5</p><p>Changes in Antimicrobial Therapy as a Result of Specific Diagnoses Provided by TTNB</p><p>Patient Date of FNA Indication for TTNB ∗ Antimicrobial Treatment Before TTNB Specific Diagnosis Provided by TTNB Antimicrobial Treatment After TTNB A December 1999 Infection None_Nocardia asteroides_ Imipenem, trimethoprim-sulfamethoxazole B January 2003 Infection/malignancy L-AMB_Aspergillus_ sp Voriconazole C November 2003 Infection Fluconazole, caspofungin_Aspergillus_ sp Voriconazole D April 2004 Infection L-AMB_Aspergillus_ sp Voriconazole and caspofungin added E October 2005 Infection Fluconazole_Aspergillus_ sp Voriconazole F April 2006 Infection Voriconazole_Actinomyces odontolyticus_ Penicillin G March 2007 Infection/malignancy None Zygomycetes Posaconazole H Jul 2007 Infection L-AMB_Candida albicans_ Fluconazole</p><p>FNA, fine-needle aspiration; L-AMB, liposomal amphotericin B; TTNB, transthoracic needle biopsy.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 6</p><p>Relationship of a Specific Diagnosis of Infection Established with TTNB to Clinical Risk Factors for Infection</p><p>Clinical Risk Factor Total Number Cases Providing Specific Diagnoses of Infection ( <em>n</em> = 10) Cases Providing No Diagnosis of Infection ( <em>n</em> = 43)<em>P</em> Neutropenic patients .02 Not within 1 mo before or at TTNB 25 (47.2%) 1 (10%) 24 (55.8%) Within 1 mo before, not at, TTNB 15 (28.3%) 5 (50%) 10 (23.3%) At TTNB only 13 (24.5%) 4 (40%) 9 (20.9%) HSCT 1.00 Yes 13 (24.5%) 2 (20%) 11 (26.6%) No 40 (75.5%) 8 (80%) 32 (74.4%) Time between last cycle of chemotherapy and TTNB (mo) ( <em>n</em> = 47) 1.9 (0–125.5) 1.5 (0–125.5) ∗ 2.2 (0–81.5) † .74</p><p>HSCT, hematopoietic stem cell transplantation; TTNB, transthoracic needle biopsy.</p><p>Data are expressed as number (percentage) or as median (range).</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="outcomes"><span class="mr-2">Outcomes</span><a href="#outcomes" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusion"><span class="mr-2">Conclusion</span><a href="#conclusion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. White D.A., Wong P.W., Downey R.: The utility of open lung biopsy in patients with Hematologic malignancies. Am J Respir Crit Care Med 2000; 161: pp. 723-729.</p><li><p>2. Fishman JA. Approach to the immunocompromised patient with fever and pulmonary infiltrates. Available at: http://www.uptodate.com . Accessed November 14, 2008.</p><li><p>3. Wong P.W., Stefanec T., Brown K., et. al.: Role of fine-needle aspirates of focal lung lesions in patients with hematologic malignancies. Chest 2002; 121: pp. 527-532.</p><li><p>4. Salonen J.H.: Successful management of cerebral and pulmonary mucormycosis with liposomal amphotericin B in a 28-year-old woman with acute lymphoblastic leukemia. Acta Biomed 2006; 77: pp. 28-31.</p><li><p>5. Kuhlman J.E., Fishman E.K., Burch P.A., et. al.: Invasive pulmonary aspergillosis in acute leukemia. The contribution of CT to early diagnosis and aggressive management. Chest 1987; 92: pp. 95-99.</p><li><p>6. Rubin R.H.: Clinical approach to infection in the compromised host.4th ed2002.SpringerNew York</p><li><p>7. Chung T.: Fine needle aspiration of the solitary pulmonary nodule. Semin Thorac Cardiovasc Surg 2002; 14: pp. 275-280.</p><li><p>8. Cahill A.M., Baskin K.M., Kaye R.B., et. al.: CT-guided percutaneous lung biopsy in children. J Vasc Interv Radiol 2004; 15: pp. 955-960.</p><li><p>9. Lacasse Y., Wong E., Guyatt G.H., et. al.: Transthoracic needle aspiration biopsy for the diagnosis of localised pulmonary lesions: a meta-analysis. Thorax 1999; 54: pp. 884-893.</p><li><p>10. Hehn S.T., Grogan T.M., Miller T.P.: Utility of fine-needle aspiration as a diagnostic technique in lymphoma. J Clin Oncol 2004; 22: pp. 3046-3052.</p><li><p>11. Arslan S., Yilmaz A., Bayramgürler B., et. al.: CT-guided transthoracic fine needle aspiration of pulmonary lesions: accuracy and complications in 294 patients. Med Sci Monit 2004; 8: pp. CR493-CR497.</p><li><p>12. Zihlif M., Khanchandani G., Ahmed H.P., et. al.: Surgical lung biopsy in patients with hematological malignancy or hematopoietic stem cell transplantation and unexplained pulmonary infiltrates: improved outcome with specific diagnosis. Am J Hematol 2005; 78: pp. 94-99.</p><li><p>13. Nosari A., Anghilieri M., Carrafiello G., et. al.: Utility of percutaneous lung biopsy for diagnosing filamentous fungal infections in hematologic malignancies. Haematologica 2003; 88: pp. 1405-1409.</p><li><p>14. Carrafiello G., Lagana D., Nosari A.M., et. al.: Utility of computed tomography (CT) and of fine needle aspiration biopsy (FNAB) in early diagnosis of fungal pulmonary infections. Study of infections from filamentous fungi in haematologically immunodeficient patients. Radiol Med 2006; 111: pp. 33-41.</p><li><p>15. Choi C.-M., Um S.-W., Yoo C.-G., et. al.: Incidence and risk factors of delayed pneumothorax after transthoracic needle biopsy of the lung. Chest 2004; 126: pp. 1516-1521.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-16/'>Volume 16</a>, <a href='/categories/issue-11/'>Issue 11</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Diagnostic%20Efficacy%20and%20Safety%20of%20Computed%20Tomography-Guided%20Transthoracic%20Needle%20Biopsy%20in%20Patients%20with%20Hematologic%20Malignancies%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fdiagnostic-efficacy-and-safety-of-computed-tomography-guided-transthoracic-needle-biopsy-in-patients%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Diagnostic%20Efficacy%20and%20Safety%20of%20Computed%20Tomography-Guided%20Transthoracic%20Needle%20Biopsy%20in%20Patients%20with%20Hematologic%20Malignancies%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fdiagnostic-efficacy-and-safety-of-computed-tomography-guided-transthoracic-needle-biopsy-in-patients%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fdiagnostic-efficacy-and-safety-of-computed-tomography-guided-transthoracic-needle-biopsy-in-patients%2F&text=Diagnostic%20Efficacy%20and%20Safety%20of%20Computed%20Tomography-Guided%20Transthoracic%20Needle%20Biopsy%20in%20Patients%20with%20Hematologic%20Malignancies%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/abr-seminar/"><div class="card-body"> <em class="small" data-ts="1257008400" data-df="ll" > Oct 31, 2009 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>ABR Seminar</h3><div class="text-muted small"><p> In August, I attended the 10th seminar, or summit, as they called it, organized by the American Board of Radiology (ABR) Foundation. The topic was “Medical Imaging: Addressing Overutilization in th...</p></div></div></a></div><div class="card"> <a href="/posts/chest-radiographic-anatomy-retention/"><div class="card-body"> <em class="small" data-ts="1257008400" data-df="ll" > Oct 31, 2009 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Chest Radiographic Anatomy Retention</h3><div class="text-muted small"><p> Rationale and Objectives The aim of this study was to verify earlier work on learning and retaining chest radiographic anatomy introduced during preclinical education and revisited in the clinical...</p></div></div></a></div><div class="card"> <a href="/posts/comparative-evaluation-of-the-fecal-tagging-quality-in-ct-colonography/"><div class="card-body"> <em class="small" data-ts="1257008400" data-df="ll" > Oct 31, 2009 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Comparative Evaluation of the Fecal-Tagging Quality in CT Colonography</h3><div class="text-muted small"><p> Rationale and Objectives The purpose of this evaluation was to compare the tagging quality of a barium-based regimen with that of iodine-based regimens for computed tomographic (CT) colonography. ...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/ct-guided-biopsies-of-pancreatic-lesions-impact-of-contrast-application-prior-to-versus-following-n/" class="btn btn-outline-primary" prompt="Older"><p>CT-Guided Biopsies of Pancreatic Lesions Impact of Contrast Application Prior to versus Following Needle Placement</p></a> <a href="/posts/diffusion-weighted-imaging-characteristics-of-primary-central-nervous-system-germinoma-with-histopat/" class="btn btn-outline-primary" prompt="Newer"><p>Diffusion-Weighted Imaging Characteristics of Primary Central Nervous System Germinoma with Histopathologic Correlation</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
